The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what happens to e4 carriers when they're dying at 60 or 65 i mean what i'm trying to say is what doesn't happen to apoe4 carriers when they're dying at 65 they don't get alzheimer's in that regards it might provide a plausible explanation of why this ancestral gene worked for us in the past but may not work for us in this modern aging population
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.